Fewer Cancer Visits; More Breast Cancer, Younger Women; Diet and Prostate Cancer - MedPage Today
Patient visits for cancer care have decreased significantly since the onset of the COVID-19 pandemic, according to one of the first systematic studies supporting anecdotal reports. (Jefferson Health, JCO Clinical Cancer Informatics)
One-fourth of patients with previously treated high-risk myelodysplastic syndromes responded to selinexor (Xpovio), and another 52% had stable disease. (The Lancet Haematology)
AstraZeneca and Daiichi Sankyo entered into a second multibillion dollar oncology agreement in as many years, this time to develop an antibody-drug conjugate cancer therapy targeting TROP-2. (Reuters)
A television news reporter learned she had thyroid cancer after a viewer wrote her about a suspicious lump on the reporter's neck. (CNN)
GlaxoSmithKline and genetic-testing company 23andMe launched a cancer clinical study, the first of multiple planned early-stage trials to use genetic information to develop new drugs. (Bloomberg)
Two lung cancer organizations announced a grant program to support studies of patients with lung cancer and COVID-19. (Lung Ambition Alliance, International Lung Cancer Foundation)
A study of global trends in breast cancer rates revealed a concerning increase among younger women living in higher-income nations. (University of Calgary, The Lancet Global Health)
A urine test for adrenal cancer could have a major impact on early diagnosis. (University of Birmingham, The Lancet Diabetes & Endocrinology)
An artificial intelligence system achieved near-perfect accuracy for identifying cancer in prostate biopsy specimens. (University of Pittsburgh Medical Center, The Lancet Digital Health)
More evidence that a "healthy diet" can reduce the risk of prostate cancer. (National Institute of Scientific Research [Canada], Nutrients)
Promising early results with a therapeutic vaccine to make HER2-positive breast cancer more responsive to immunotherapy. (Duke Health, Clinical Cancer Research)
Comments
Post a Comment